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9AbstrACt
Health care associated infections (HCAI) affect roughly four million people in Europe annually, 
resulting in 16 million extra days of hospital stay, 37 000 attributable deaths and direct costs 
of approximately € 7 billion. HCAI in vascular surgery are relatively common complications 
with potentially devastating consequences. The aim of this thesis, based on four papers, was to 
study the scope of these complications and investigate the viability of methods for large-scale 
follow-up of patients after discharge and potentially more accurate laboratory diagnostic tools 
for postoperative infections.
The first paper, which is also the first of the two epidemiological studies included 10 547 
patients who had undergone elective, infrainguinal revascularization – open or endovascular 
– during the period 2005-2010. Data were collected from the Swedish National Registry for 
Vascular Surgery (Swedvasc), the Swedish National Patient Register (NPR) and the Cause of 
Death Register. The total incidence of HCAI within 30 days was 9.7% (n = 1 019). The rate of 
30-day HCAI for endovascular procedures was 7.8% (490/6 262) and for bypass operations 
13.3% (430/3 224). The rate of major amputation at one-year was 11.8% (98/833) for patients 
with postoperative HCAI and 5.6% (446/7 933) for those without HCAI postoperatively. 
The second paper, a prospective, clinical pilot-study, evaluated the effect of surgically induced 
inflammation on neutrophil CD64 receptors, which have been shown to undergo a rapid up-
regulation in response to bacterial infection. This study included 153 elective, vascular patients. 
The results showed a non-significant effect of surgical trauma on CD64 receptors, as well as, a 
significant increase in CD64 expression postoperatively, in response to bacterial infection. The 
third paper aimed to investigate some of the cellular responses to surgical trauma and infection 
by measuring the changes in serum concentration of an array of cytokines in 96 consecutive 
patients undergoing non-emergent vascular surgery. The results showed a decrease in eight 
pro-inflammatory cytokines and a positive correlation between perioperative infection and the 
anti-inflammatory cytokines, interleukin (IL)-10 and IL-13.
The fourth paper, which included a similar cohort to the first paper, collected data on 9 894 
patients from Swedvasc, NPR and the Prescribed Drug Register, between 2005 and 2010. The 
aim of this study was to determine the rate and type of postoperative HCAI, after discharge 
from hospital, using antibiotic prescription as a surrogate marker. We have shown that 33% 
of patients received an antibiotic prescription within 30 days of the index operation. In the 
endovascular group, there was a 52% increase in the rate of prescriptions postoperatively 
compared to the preoperative period. Prescriptions for urinary tract infections dominated the 
30-day postoperative period for patients with claudication.
The rates of postoperative HCAI after lower limb revascularization warrant a more extensive 
follow-up regimen, including post-discharge, for both open and endovascular procedures. The 
need for more accurate laboratory tests in the early postoperative period still remains to be 
fulfilled. Neutrophil CD64 in combination with other markers, such as IL-10 and C-reactive 
protein have shown potential in this area and merit further investigation. 
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PoPulärvetenskAPlig sAmmAnfAttning
De vanligaste komplikationerna inom sjukvården är vårdrelaterade infektioner (VRI). Enligt 
Världshälsoorganisationen (WHO), drabbas årligen över fyra miljoner människor i Europa, 
resulterande i 16 miljoner extra dagar av sjukhusvistelse samt 37 000 relaterade dödsfall och 
en direkt kostnad på ca € 7 miljarder.
Inom epidemiologisk och klinisk forskning ingår i klassificering av VRI vanligen 
urinvägsinfektion, luftvägsinfektion, postoperativ sårinfektion och blodburen infektion. 
Postoperativa VRI inom kärlkirurgi kan få ytterst allvarliga konsekvenser och uppskattad 
incidens inom en månad efter operation är uppemot 35 %. Dessa infektioner är vanligast efter 
kärlkirurgiskt ingrepp på benen. Tidig diagnostik och behandling av infektion är avgörande för 
ett gynnsamt utfall. Kateterbaserade (endovaskulära) ingrepp som numera utgör mer än hälften 
av alla kärlkirurgiska ingrepp, är ofta utförda på dagkirurgiska enheter, vilket kan försvåra 
uppföljning och identifiering av eventuella postoperativa VRI inom denna grupp. Den tidiga 
laboratoriebaserade diagnostiken av en eventuell infektion försvåras av den inflammatoriska 
effekten av kirurgi. Idag saknas det tester som kan åtskilja mellan inflammation förorsakad av 
kirurgi och infektion. 
Syftet med denna avhandling är att undersöka omfattningen av VRI bland kärlkirurgiska 
patienter på nationell basis, utforska användbarheten av nya laboratoriemetoder för tidig 
diagnostik och utvärdera epidemiologiska metoder för uppföljning av patienter, även efter 
utskrivning från sjukhus.
I de två epidemiologiska studierna (Studie I och IV), har vi kartlagt förekomsten av VRI efter 
planerade kärlkirurgi på benens pulsådror. Vi samlade in data från det svenska kärlregistret 
(Swedvasc), Patientregistret, Läkemedelsregistret och Dödsorsaksregistret. Studierna 
inkluderade 10 547 (Studie I) och 9 894 (Studie IV) patienter under perioden 2005-2010. Data 
från Läkemedelsregistret har använts för att identifiera postoperativa infektioner efter utskrivning 
från sjukhus genom att jämföra antibiotika förskrivning före och efter operation. Den totala 
förekomsten av VRI inom 30 dagar efter kärlkirurgi var 9.7%. För endovaskulära ingrepp var 
30-dagars förekomst 7.8% och för bypassoperationer 13.3%. Amputationsfrekvensen inom ett 
år för de med och utan postoperativ VRI var 12 % respektive 5,6 %. Totalt sett hade 33 % av 
patienterna hade fått minst ett recept på antibiotika efter ett planerat kärlkirurgiskt ingrepp. 
I den endovaskulära gruppen var det en 52% ökning i frekvensen av antibiotikaförskrivning 
efter operation jämfört med perioden före operationen. Förskrivningen för antibiotika mot 
urinvägsinfektioner inom 30 dagar efter ingrepp var den största antibiotikagruppen bland 
patienter med fönstertittarsjuka (claudicatio).
I den andra och tredje studien, båda prospektiva kliniska studier, har vi undersökt den potentiella 
användbarheten av olika inflammatoriska markörer som laboratorietester för postoperativ 
infektion. I den andra studien (153 patienter), har vi undersökt effekten av kirurgiskt trauma 
samt bakteriell infektion på uppgradering av CD64 receptorer på en subgrupp av vita 
blodkroppar (neutrofiler). Vi har visat en kliniskt icke-signifikant effekt av kirurgiskt inducerad 
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inflammation på CD64 receptorerna. Resultaten visade också en signifikant upp-gradering av 
CD64 i respons till bakteriellinfektion. Den tredje studien (96 patienter), fokuserade på effekten 
av kirurgisktrauma och infektion på cytokiner som fungerar som signalmolekyler mellan 
cellerna. Resultaten visade en nedgång i postoperativa värden för åtta pro-inflammatoriska 
cytokiner och en positiv korrelation mellan två anti-inflammatoriska cytokiner, interleukin 
(IL)-10 och IL-13, och postoperativa infektioner.
Den höga förekomsten av VRI efter kärlkirurgiska ingrepp på benen understryker behovet av 
ett nogrgrannt uppföljningsprogram under den postoperativa perioden efter utskrivning. CD64 
i kombination med andra markörer som IL-10 har visat en viss potential som en förbättrad 
laboratoriemarkör för postoperativ infektion men mer omfattande klinisk forskning krävs 
innan detta kan säkerställas.
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introduCtion
Historical perspective
The concept of healthcare related infections, traditionally referred to as nosocomial (Greek: 
“nosus” = “disease” + “komeion” = to take care of) infections, is as old as the practice of 
medicine itself. According to a Sanskrit textbook of medicine, Charaka-Samhita from c. fourth 
century B.C., the principles to be followed when constructing a hospital were as follows: 1
“It should be spacious and roomy. One portion at least should be open to the currents of wind. 
It should not be exposed to smoke, or dust, or injurious sound or touch or taste or form or 
scent…After this should be secured a body of attendants of good behaviour, distinguished for 
purity and cleanliness of habits.”
Hippocrates c. 460 – c. 370 B.C. notes, concerning the treatment of wounds that “the surgeon 
should aim at keeping the wound dry, that condition being a healthier one than when it is wet…
Wounds should be permitted to bleed freely and be carefully cleansed.” 2
These ancient teachings seem, however, to have been generally shunned during the Middle 
Ages as demonstrated by a comment about the 16th century Paris hospital, Hôtel-Dieu:  1
“A young surgeon who is bred in the Hôtel-Dieu, may learn the various forms of incisions, 
operations too, and the manner of dressing wounds; but the way of curing wounds he cannot 
learn. Every patient he takes in hand must die of gangrene.”
 
Figure I. Hôtel Dieu in Paris, c. AD 1500. The priest 
on the right is issuing the last sacraments, while a 
nun administers to the patient on the left. Patients 
often slept two, three and even four to a bed. 
Source: Google Images
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These conditions provided, through the force of necessity, a breeding ground for experimentation 
and new ways of thinking. Ambroise Paré (c. 1510-1590), considered to be the father of French 
surgery, broke with the tradition of cauterising traumatic wounds with red-hot iron and instead 
adopted the practice of ligation, débridement and dressing of wounds.  2
It took approximately another two centuries after Paré for a return to the old principles of 
hospital hygiene as exemplified by an account of the newly built Edinburgh Royal Infirmary 
in 1739: 1
“The beds are designed only to hold one Person… the House is kept clean and sweet; you 
find nothing in it to offend either your Smell or your Eye; the Patients are used with great 
tenderness, and the Order established in the House, gives great satisfaction.”
One of the noteworthy physicians during this era, as highlighted by Selwyn (1965) was Sir 
John Pringle, physician to the British Army, who observed that a major cause of morbidity 
and mortality among soldiers were the hospitals themselves. His major contributions in this 
field included his insistence on improved ventilation and avoiding overcrowding in wards and 
indeed, beds. He also played a pioneering role in the epidemiological study of “hospital-fever” 
and postulated about the causes of infection in his “Experiments on Septic and Antiseptic 
Substances.” Other notable contributions from the same period include, Alexander Gordon’s 
theory on the transmission of “puerperal fever” by the hands and clothing of personnel. This 
was followed, almost five decades later, by Semmelweis in Vienna, where he used chlorine 
solution to “deodorize attendants’ hands.” Parallel to these efforts, Sir James Simpson 
published his seminal works on “Hospitalism” in which he charted postoperative mortality 
after amputaions in various healthcare institutions. One of the major conclusions of this work 
was the observation that the rate of mortality was proportional to the size of the institution and 
degree of overcrowding.  1
The culmination of these advances can be seen in the better known and widely acknowledged 
practices and discoveries of Joseph Lister by desinfection of surgical wounds with carbolic acid 
to avoid infection and sepsis; Louis Pasteur’s establishment of the “germ theory of infection” 
and Sir Alexander Fleming’s discovery of penicillin, which revolutionized modern medicine.
Healthcare associated infections (HCAI) – clinical burden and implications
The most common complications in clinical care are acquired infections resulting from contact 
with healthcare facilities. The World Health Organization (WHO) defines HCAI as: ”An infection 
occurring in a patient during the process of care in a hospital or other healthcare facility which was 
not present or incubating at the time of admission. This includes infections acquired in the hospital, 
but appearing after discharge, and also occupational infections among staff of the facility.” 
 
It is estimated that annually, over four million people in Europe are affected, resulting in 16 
million extra days of hospital stay, 37 000 attributable deaths and direct costs of approximately 
€ 7 billion. 3
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HCAIs can be broadly divided into two groups based on the source of the infectious agent: 
an endogenous source, which refers to the bacterial flora on the skin and the bodily cavities, 
or an exogenous source, which is transmitted to the patient via contact with the healthcare 
environment. In clinical and epidemiological practice, HCAIs are generally classified as, 
urinary tract infections (UTI), respiratory tract infections (RTI), surgical site infections (SSI) 
or, bloodstream infection (BSI). A European report from 2008 found that the most frequent 
type of HCAI was UTI (27%), followed by RTI (24%), SSI (17%) and BSI (10,5%). 4
Postoperative HCAI in vascular surgery have an estimated 30-day incidence of up to 35%. 5 
The use of prosthetic grafts in aortic surgery and various vascular reconstructions in the limbs 
implies serious consequences in the event of an infection. 6, 7 Early diagnosis and treatment 
are therefore of utmost importance. The steady advance of endovascular techniques, often 
performed on an outpatient basis, poses new challenges to the follow-up of this group of 
patients.
One of the most challenging aspects of dealing with HCAI, from an epidemiological point of 
view, is the choice of surveillance method. 8, 9, 10 Although, a prospective method is considered 
the gold standard, it is also the most demanding in terms of resources. 11, 12  A retrospective 
design requires complete databases with a high degree of validity. A major drawback is that 
earlier definitions and criteria cannot be changed. 13 A middle ground is sometimes chosen to get 
a snapshot picture of the situation by conducting a point prevalence study, as has been done in 
the WHO study quoted earlier. The limitations of this design are mainly due to the fact that there 
cannot be any follow-up of the subjects and furthermore, historical comparisons can be difficult 
to interpret due to shifting trends in 
diagnosis and treatment. A relatively 
novel approach for circumventing the 
problem of post-discharge follow-up 
is by using a surrogate marker, such 
as antibiotic prescriptions, to track 
the postoperative course for each 
patient. 14, 15,16 
Figure II. List of patients at the Vascu-
lar Surgery ward, Karolinska University 
Hospital, Christmas 2013. Four of the 
eight vascular patients were admitted 
due to surgical site infections
Introduction
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The main purpose of a surveillance program, irrespective of the method used, is to provide a 
vision of reality, which can be used to improve the measured outcomes. A study by Haley et 
al from 1985 showed that feedback to healthcare personnel could reduce HCAI rates by 32%.
Surgical site infections (SSI)
The vulnerability of vascular procedures to postoperative infections and specifically, the 
susceptibility of infrainguinal procedures to SSI warrant a more detailed look at this particular 
type of HCAI. 17, 18 The Centers for Disease Control and Prevention (CDC) defines SSI as 
either incisional or organ/space. Incisional SSIs are further divided into Superficial and Deep 
incisional SSIs occurring within 30 days of the operation. Organ/space SSIs involve other parts 
of the anatomy, other than the incision, manipulated during the operation. 19
Table I. Adapted from Centers for Disease Control and Prevention (CDC) Criteria for Surgical 
Site Infection (SSI), Horan TC et al 1992
superficial incisional ssi
Infection occurs within 30 days after the operation and infection involves only skin or 
subcutaneous tissue of the incision and at least one of the following:
1. Purulent drainage, with or without laboratory confirmation, from the superficial incision.
2. Organisms isolated from an aseptically obtained culture of fluid or tissue from the 
superficial incision.
3. At least one of the following signs or symptoms of infection: pain or tenderness, 
localized swelling, redness, or heat and superficial incision is deliberately opened by 
surgeon, unless incision is culture-negative.
4. Diagnosis of superficial incisional SSI by the surgeon or attending physician.
Do not report the following conditions as SSI:
1. Stitch abscess (minimal inflammation and discharge confined to the points of suture 
penetration).
2. Incisional SSI that extends into the fascial and muscle layers (see deep incisional SSI).
deep incisional ssi
Infection occurs within 30 days after the operation if no implant is left in place or within 
1 year if implant is in place and the infection appears to be related to the operation and 
infection involves deep soft tissues (e.g., fascial and muscle layers) of the incision and at 
least one of the following:
1. Purulent drainage from the deep incision but not from the organ/space component of the 
surgical site.
2. A deep incision spontaneously dehisces or is deliberately opened by a surgeon when the 
patient has at least one of the following signs or symptoms: fever (>38ºC), localized pain, or 
tenderness, unless site is culture-negative.
3. An abscess or other evidence of infection involving the deep incision is found on direct 
examination, during reoperation, or by histopathologic or radiologic examination.
4. Diagnosis of a deep incisional SSI by a surgeon or attending physician.
21
organ/space ssi
Infection occurs within 30 days after the operation if no implant is left in place or within 
1 year if implant is in place and the infection appears to be related to the operation and 
infection involves any part of the anatomy (e.g., organs or spaces), other than the incision, 
which was opened or manipulated during an operation and at least one of the following:
1. Purulent drainage from a drain that is placed through a stab wound into the organ/space.
2. Organisms isolated from an aseptically obtained culture of fluid or tissue in the organ/
space.
3. An abscess or other evidence of infection involving the organ/space that is found on direct 
examination, during reoperation, or by histopathologic or radiologic examination.
4. Diagnosis of an organ/space SSI by a surgeon or attending physician.
 
Other classification systems, specific to vascular surgery include Szilagyi 20, Samson 21, and 
Karl-Storck 22 that put more emphasis on the eventual involvement of vascular grafts and 
anastomoses.
Figure III. Three categories of SSI, adapted from Centers for Di-
sease Control and Prevention (CDC),
 illustrated by Hanna Daryapeyma
Introduction
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Table II. SSI classification systems in vascular surgery
Class szilagyi samson Karl-storck
1 Infection involves only the dermis
Infection extends 
no deeper than the 
dermis
Superficial infection 
without involvement of 
the graft
2
Infection 
extends into the 
subcutaneous 
tissue but does not 
involve the arterial 
implant
Infections involve 
subcutaneous 
tissues but do not 
come into grossly 
observable contact 
with the graft
Partial graft infection 
without involvement of 
the anastomosis
3 Infection involves the arterial implant
Infections involve 
the body of the 
graft but not at an 
anastomotic site
Involvement of the 
anastomosis and the 
suture line
4
Infection surrounds 
an exposed 
anastomosis, 
but bacteremia 
or anastomotic 
bleeding has not 
occurred
Wound disruption and 
complete exposure of the 
graft/patch
5
Infection involves 
a graft-to-artery 
anastomosis and 
is associated 
with septicemia 
and/or bleeding 
at the time of 
presentation
1-4 with concomitant 
septic bleeding/
pseudoaneurysm
6 1-4 with graft thrombosis or septic embolization
Pathogenesis of SSI 
The development of SSI is contingent on the interplay among three factors: microbial, 
patient and surgical characteristics. Endogenous contamination from the patient’s skin flora 
is the most common cause of surgical wound contamination. Other microbial related factors 
include the bacterial load and virulence. 23 Inclusion of prosthetic materials increases the 
susceptibility of the wound to infection as the number of organisms needed to cause an 
infection decrease. 24 The virulence of the organisms is dependent on intrinsic factors such 
as, the ability to bind to tissues and protect themselves from the onslaught of the immune 
system. The formation of a glycocalyx biofilm is one such defence mechanism. 25, 26 The 
patient characteristics that can influence the emergence and outcome of SSI include age, 
comorbidities e.g. diabetes mellitus and obesity and concomitant medications such as 
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immunosuppressants. 27, 28, 29 The surgical characteristics relevant to SSI are length of surgery, 
type of wound and the need for blood transfusion. 30, 31, 32
Microbiology of SSI 
The most prevalent bacteria isolated from SSI in vascular surgery patients are Gram-positive 
bacteria, in particular Staphylococcus aureus, which is reported to account for up to 80% 
of infections. 17, 33 Chronic graft infections with late clinical presentation are usually caused 
by S.epidermidis and it is estimated that approximately 20% of vascular SSI are caused 
by Gram-negative bacteria, which include Escherichia coli, Pseudomonas aeruginosa and 
Klebsiella pneumonia. The pattern of infections is subject to geographical variations and 
different practices regarding the use of antibiotics. Several countries in Europe and North 
America have seen a rise in the number SSI caused by methicillin-resistant Staphylococcus 
aureus (MRSA). 34
Laboratory markers of infection
The immune system can be broadly divided into two main branches - the specific and the 
native or innate. The former possesses specificity and memory but is not initially efficient in 
eliminating bacteria, unless previously primed. The native immune system includes among 
other cell types, monocytes and polymorphonuclear neutrophiles (PMN). PMN are mainly 
involved in phagocytosis and are regulated by cytokines released by other immune competent 
cells. The neutrophil is the main circulating phagocyte that is delivered to a site of infection. 
Its function is regulated by changes in the cell membrane that are in turn affected by various 
receptors. 35
Cytokines 
Cytokines are a group of polypeptides secreted by cells in response to injury and have a 
central role in mediating the inflammatory response. Their purpose is to organize a concerted 
response to tissue trauma, which involves recruitment of cells to the site of injury and 
instigation of a systemic response. 36 Cytokines can generally be classified according to 
their effects on the inflammatory process e.g. stimulatory or inhibitory. Pattern recognition 
receptors, such as toll like receptors, recognize bacteria and stimulate the secretion of pro-
inflammatory cytokines interleukin-1β (IL-1β), IL-6, IL-8, and tissue necrosis factor- α (TNF- 
α)  37 IL-1 (α/β) and TNF (α/β) are pro-inflammatory cytokines that can induce fever and 
stimulate the synthesis of IL-6 which in turn sets into motion a cascade of pro-inflammatory 
and self-regulating anti-inflammatory responses which steer the immune response.
C-reactive protein (CRP) 
Tissue damage and acute inflammation, whether caused by surgical trauma or infection, 
elicits an acute response, which involves the secretion of acute phase proteins, of which 
CRP is one of the most scrutinized. Its name was derived from its ability to bind the 
C-polysaccharide of Streptococcus pneumonia and was the first pattern recognition receptor 
to be identified. 38, 39, 40 CRP production in the liver is induced mainly by IL-6, but also IL-1 
and TNF-α. 41 CRP has a high affinity for phosphocholine residues on damaged or dead 
cells as well certain microorganisms. The complex formed by CRP and the bound ligands 
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triggers the complement system through recognition by C1q and leads to the stimulation of 
phagocytosis. Up-regulation of CRP synthesis is rapid (within hours) and its plasma half-life, 
which remains constant under most conditions, is about 19 hours. 38
Quantitative measurements of plasma CRP continue to form the corner stone of clinical 
evaluation of infection, however, due to insufficient sensitivity and specificity, they cannot 
stand on their own.
Procalcitonin (PCT) 
PCT is the prohormone to calcitonin, normally produced by the C-cells of the thyroid in 
response to hypercalcemia. Its normal circulating levels in plasma are extremely low and 
it has a half-life of 20-24 hours. In response to inflammatory stimuli such as bacterial 
endotoxins, procalcitonin is released from non-neuroendocrine parenchymal cells in the 
liver, lungs and the intestine. 42, 43 Studies have shown that PCT production is rapidly 
upgraded reaching readily detectable levels within 6-12 hours in response to tissue damage. 
44 The use of PCT as a routine laboratory marker for bacterial infections has been hindered 
by its relative insensitivity to local bacterial infections and a general increase in plasma 
concentrations in the early postoperative period. 45, 46, 47
Neutrophil CD64 (FcγRI) 
The neutrophil CD64 (cluster of differentiation 64) receptor, also known as FcγRI, is a 
glycoprotein that binds monomeric immunoglobulin G (IgG)-type antibodies with high 
affinity. 48 CD64 is a potent cytotoxic trigger expressed exclusively on mononuclear 
phagocytes and activated polymorphonuclear (PMN) leucocytes. 49 PMN CD64 analysis 
has been shown to have a high sensitivity and specificity for the early detection of bacterial 
infection. 50, 51 The up-regulation of CD64 receptors is modulated partly, by the release of 
interferon- γ (IFN-γ) from natural killer cells (NK-cells) exposed to IL-15 and IL-18. 52
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Aims of the thesis
The general aim of this thesis has been to chart the scope of postoperative infectious 
complications in vascular surgery, especially after lower extremity procedures, and to 
evaluate methods for both early diagnosis of infection and extensive follow-up of patients. 
Accordingly, the work can be divided into two parts: 
1. Epidemiological studies to reveal the extent of postoperative HCAI on a nationwide 
scale and to evaluate the feasibility of post-discharge follow-up using the available 
national databases.
2. Clinical investigations of possible new laboratory markers for bacterial infections 
after vascular surgery.
The chronological order of the studies, however, does not follow the abovementioned 
division into two phases, but rather, reflects the order of my interest and progression in this 
field. The order of presentation of the studies in this thesis has, therefore, been arranged to 
follow a more logical thread.
The specific aims of the studies were as follows:
• To evaluate the rate of healthcare associated infections (HCAI) and related risk factors in 
patients treated for lower extremity arterial disease on a national basis, thereby providing 
a means of assessing the choice of treatment and likely outcomes for different patient 
categories (Study I).
• To evaluate the clinical utility of quantitative CD64 measurements to differentiate 
between inflammation in response to surgical trauma and postoperative bacterial infection 
(Study II).
• To assess the cytokine response to the acute inflammation caused by vascular surgery and 
to evaluate the potential for the clinical utility of quantitative measurements of cytokines 
as markers for infection in conjunction with CRP and CD64 (Study III).
• To investigate the rate and pattern of HCAI and related risk factors in patients treated 
for lower extremity arterial disease on a national basis using antibiotic prescription as a 
surrogate marker for postoperative HCAI (Study IV).
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methods And PAtients
The two epidemiological studies were retrospective analysis of prospectively collected data 
from national databases and the two clinical studies were single-centre, prospective cohort 
studies.
Table III. List of studies
study design Method Place & date
i
Nationwide 
retrospective cohort
Cross-matching of 
national databases Stockholm, 2014
ii Single-centre prospective cohort
Consecutive inclusion of 
eligible subjects Bergen, 2009
iii Single-centre prospective cohort
Consecutive inclusion of 
eligible subjects
Stockholm/Bergen, 2014
iV
Nationwide 
retrospective cohort
Cross-matching of 
national databases Stockholm, 2015
The epidemiological studies (I and IV)
Design
Retrospective analysis of prospectively collected data from the Swedish National Vascular 
Surgery registry (Swedvasc), National Patient Registry (NPR), Prescribed Drug Register 
(PDR) and Cause of Death Register.
Population 
All patients who underwent non-emergent primary infrainguinal surgery, open or 
endovascular, for lower extremity arterial disease between January 2005 and December 2010 
were included in the study. Patients with secondary procedures, reoperations or combined 
endovascular and open surgery were excluded (n = 2 763). Only primary surgery/intervention 
in the time span for each patient was included in the analysis. 10 547 patients were included 
in Study I and 9 894 in Study II.
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Data sources 
The Swedish National Registry for Vascular Surgery (Swedvasc), the Swedish National 
Patient Register (NPR), the Prescribed Drug Register (PDR) and the Cause of Death Register 
were used as data sources to collect information about patients who have undergone either 
open or endovascular lower extremity revascularization during the study period. Using 
the subjects Civic Registration Number (CRN), which is registered at every contact with 
the health authorities, facilitated the cross- matching of data between different databases. 
The external validity of Swedvasc has been shown to be over 90%. 53 All contacts with 
healthcare providers whether hospitals or community care providers are registered at the 
NPR. According to a recent report, the rate of missing main diagnosis code was 0.9% for 
hospital admissions and 10% for primary care contacts.54 In Sweden, antibiotics can only be 
obtained through a medical prescription at certified pharmacies. Starting 2005, the Prescribed 
Drug Register (PDR) contains data (type, dose, total amount and time) on all dispensed 
prescriptions, on an out-patient basis and is linked to the CRN, providing basic demographic 
data such as age and gender. Drugs prescribed and administered in-hospital are not included 
in the register. All deaths, including their causes are registered in the national Cause of Death 
Register. 
Data management 
Data regarding demographics, presenting symptoms, comorbidities/risk factors, type of 
procedure and follow-up visits at 30-days and one-year were collected from Swedvasc. These 
were cross-matched with the NPR and the Cause of Death Register in the first study and NPR 
and PDR data in the fourth study. The Swedvasc data were stratified according to severity 
of lower extremity symptoms and types of procedure. NPR data regarding postoperative 
complications were categorized into skin-and-soft-tissue infections, including SSI, urinary 
tract infections (UTI), pneumonia and sepsis. PDR data - regarding antibiotic prescription 
and dispensation - in the fourth study were classified into three categories based on their 
main therapeutic indications and time of dispensation relative to the index operation (a six-
month period leading up to the index operation and a six-month period after the operation 
for each patient (Fig.  II). The postoperative prescription data were further divided into two 
groups; the first pertaining to the one-month period after the operation and the second to the 
remaining five months).
 6 Months                                  30 Day  5 Months
                                  Index Operation
Figure IV. Time axis for antibiotic prescriptions
Statistical methods
Study I 
Data were presented as the number and proportion of patients for each independent variable 
both as a total and the proportion with an infection within 30 days. 
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The impact of the selected variables on all types of infections within 30 days were analysed 
using logistic regression – with both univariate and multivariate models.
To account for missing data in the variables, all analyses were performed using multiple 
imputation with chained equations (MICE), 55 under the assumption that data were missing at 
random, conditional on the selected variables and the infection outcome. 
Estimated odds ratios of amputation within one year and death within 30 days were analysed 
using univariate and multivariate logistical regression analyses for patients with and without 
30-d infection and presented with 95% confidence intervals and p-values.
Study IV 
To measure frequency of antibiotic purchases we used incidence rates (number of purchases/
day). A Poisson model was used for comparisons between groups unless overdispersion was 
present, in which case we used a negative binomial model. Stratification was used to account 
for the effect of other variables.
When comparing periods, the groups could not be considered independent since the same 
persons were followed both before and after operation. A generalized estimating equations 
(GEE) framework was used to adjust for this dependency.
P < .05 was considered to be statistically significant. 
Methodological considerations (Study I and IV) 
The advantages of a retrospective analysis and cross-matching of national databases with 
a high degree of validity are in the large numbers provided by the multicentre nature of 
the data which avoid the type of potential bias posed by regional differences and smaller 
numbers which can affect sub-group analyses. The major disadvantages are inherent to the 
retrospective nature of registry-based studies, especially regarding missing data and the type 
of variables recorded. Plausible alternative methods could include a nested case-control study, 
representing a more cost-effective method, which would provide us with a ratio of incidence 
rates instead of the absolute rates of outcome provided by the longitudinal cohort study. A 
point-prevalence study would also be a tenable alternative providing us with a snapshot of the 
situation, which could be used as a proxy for the longitudinal data.
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The clinical studies (II and III)
Design 
Single-centre, prospective cohort studies.
Population 
During the period 2006-2010, patients undergoing elective vascular surgery, comprised of 
carotid endarterectomy (CEA), carotid artery stenting (CAS), open aortic repair (AAA-OR), 
endovascular aortic repair (EVAR), aortoiliac/aortobifemoral bypass and open infrainguinal 
procedures, were consecutively included. Study II included 153 patients and Study III 96 
patients.
Laboratory methods 
Peripheral venous blood samples were taken preoperatively on admission and postoperatively 
during the first 24 hours. The samples were analysed for C-reactive protein (CRP), total 
leukocyte counts, serum-procalcitonin and neutrophil CD64 expression. The analyses for 
CRP (mg/L), leukocyte counts (x109 /L) and s-procalcitonin (μg/L) were performed using 
well-established laboratory protocols on the Cell Dyn Sapphire Hematology Analyzer®.
CD64 expression was measured using the LK64-H-Assay™ kit produced by Trillium 
Diagnostics, LLC on the Cell Dyn Sapphire Hematology Analyzer®. The kit contains a 
mixture of two CD64 specific monoclonal antibodies (clones 22 and 32.2) and one CD163 
specific monoclonal antibody (Mac2-158) in addition to a fluorescence bead suspension for 
standardisation of CD64 quantification. The use of two different antibodies to CD64 and the 
inclusion of an antibody to CD163, a monocyte specific antigen, increase the sensitivity and 
specificity of the assay. The analysis required 50μL of EDTA anticoagulated whole blood 
drawn peripherally and included a 10-minute incubation period. The samples were analysed 
individually and the data output from the Cell Dyn Sapphire Hematology Analyzer® was 
then fed into the Leuko64 QuantiCALC™ software which reported the results as a neutrophil 
CD64 index (PMN-MFI (Mean Fluorescence Intensity) x Bead Calibration Factor / Beads-MFI).          
Cytokines in serum were detected using the Luminex immunobead technology, 25-plex-kit 
(Invitrogen/Biosource, Carlsbad, CA, USA). In short, antibody-coupled beads were incubated 
with target analyte after which they were incubated with biotinylated detection antibody 
before finally being incubated with streptavidin–phycoerythrin. Samples were then read by 
the Luminex’s laser based fluorescent analytical test instrument Luminex® 100™ (Luminex 
Corporation Austin, TX, USA).
Blood and urine cultures were taken on the suspicion of infection. The diagnosis of infection, 
whether pre- or postoperative, was based on either a positive culture result or the presence of 
a clinically manifest wound infection. Fever was defined as body temperature ≥ 38° C.
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Study II 
The paired t-test was used for intra-group analyses and the Mann-Whitney U-test was used 
for inter-group comparisons and ROC curve analysis was used for establishing cut-off points, 
sensitivity and specificity for CRP, procalcitonin and CD64. 
Study III 
The Pearson’s r, regression analysis, student’s t-test, paired samples test, the Kruskal-Wallis, 
receiver operating characteristics (ROC) analyses and logistical regression were performed as 
indicated.
Methodological considerations (Study II and III) 
The main obstacle in studies attempting to evaluate new diagnostic methods or markers for 
infection is the confirmation of the presence or absence of infection in a clinical setting. The 
gold standard is considered to be a positive culture result, which unfortunately can be elusive. 
A standardized and validated protocol for clinical evaluation can function as an effective 
substitute. The designs of the two clinical studies could have been further strengthened by the 
inclusion of a previously defined control group and a more homogenous cohort in regards to 
exposure or type of operation.
Methods and Patients
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results And disCussion
Study I
The presenting symptoms based on the degree of lower extremity ischaemia were divided 
into claudication 27% (n=2 827), critical limb ischaemia without ulceration (CLI) 17% (n=1 
835) and gangrene 56% (n=5 885). The treatment modalities consisted of endovascular 
intervention 59% (n=6 266), thrombendarterectomy (TEA) 10% (n=1 061) and bypass 
surgery 31% (n=3 224).
The total incidence of postoperative infection (< 30-d) was 9.7% (n=1 019) including: 
 -  skin-and-soft-tissue infection 6.9%, including surgical site infection (SSI
 -  urinary tract infection (UTI) 1.6% 
 -  pneumonia 1.1%  
 -  sepsis 0.9%. 
The incidence of postoperative infections according to the degree of lower extremity 
ischaemia was: claudication 4.1%; CLI 7.5% and gangrene 13%. The rates of postoperative 
infection based on type of procedure were: endovascular 7.8%; TEA 9.3% and bypass 
surgery 13.3%. The incidence of diabetes was 49% in the gangrene group, compared to CLI 
28% and claudication 24%.
 In both claudicants and patients with CLI, TEA was associated with a higher rate of infection 
compared to endovascular procedures (OR, 6.7; 95% CI, 3.9 – 11.6, P < .001 and OR, 
2.0; 95% CI, 1.1 – 3.7, P < .001, respectively). The odds increase was even greater when 
comparing bypass surgery to endovascular for claudicants (OR, 8.4; 95% CI, 5.0 – 14, P < 
.001) and CLI patients (OR, 3.4; 95% CI, 2.3 – 5.1, P < .001) (Table IV).
Table IV. Multivariate analysis of degrees of lower extremity ischaemia and operative 
method associated with postoperative healthcare associated infections
Procedure Characteristics Multivariate or (95% C.i.) P-value
Bypass vs. Endovascular Claudication
 
8.38 (5.03-13.95) < .001
CLI
Gangrene 
3.41 (2.29-5.10)
1.39 (1.18-1.65) 
< .001
< .001
TEA vs. Endovascular Claudication 6.71 (3.89-11.55) < .001
CLI
Gangrene 
2.03 (1.12-3.69)
1.04 (0.75-1.46) 
0.019
0.808
 OR, Odds ratio; CI, confidence interval; CLI, critical limb ischaemia; TEA, thrombendarterectomy
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The overall one-year major amputation rate of 6.2% was significantly associated with 
30-day infection (OR, 2.25; 95% CI, 1.78-2.83, P < .001). Patients without postoperative 
infection had an amputation rate of 5.6%, whereas patients with postoperative infection had 
an amputation rate of 11.8%. Based on multivariate analysis, there were also significant 
associations with diabetes (OR, 1.58; 95% CI, 1.3-1.92, P < .001) and cerebrovascular 
disease (OR, 1.41; 95% CI, 1.13-1.76).
The overall 30-d mortality rate (2.7%) was associated with 30-d infection (OR, 1.7; 95% CI, 
1.22-2.37, P = .002). The degree of severity of lower extremity ischaemia was associated 
with increased mortality: CLI versus claudication (OR, 8.28; 95% CI, 3.54-19.83, P < .001); 
gangrene versus claudication (OR, 20.42; 95% CI, 9.07-45.94, P < .001). Patients without 
postoperative infection had a mortality rate of 2.5%, whereas patients with infection had a 
mortality rate of 4.2%. Using multivariate analysis, the predictors of 30-d mortality were 
degree of lower extremity ischaemia, renal insufficiency and heart disease (Table V).
Table V. Multivariate analysis of risk factors in patients undergoing lower extremity 
revascularization and association to 30-day mortality
risk factors Multivariable modelor (95% C.i.) P-value
Diabetes
Hypertension
Renal insufficiency
1.00 (0.87- 1.16) 0.997
1.00 (0.86- 1.17)  0.988
1.27 (1.06- 1.53) 0.009
Cerebrovascular disease
Heart disease
Lung disease
1.11 (0.93- 1.33) 0.252
1.15 (1.00-1.33) 0.049
1.37 (1.14- 1.65) < .001
Smoking 
Age 60-69 vs. <60
Age 70-79 vs. <60 
0.91 (0.77- 1.08) 0.280
0.83 (0.61- 1.12) 0.224
0.86 (0.64- 1.16) 0.320
Age >79 vs. <60
Female gender
0.79 (0.58- 1.07) 0.120
1.05 (0.92-1.21) 0.467
OR, Odds ratio; CI, confidence interval
We have shown that both the degree of ischaemia and the presence of preoperative 
comorbidities have a significant impact on the rate of postoperative HCAI and by extension, 
on the rates of 30-day mortality and one-year amputation. The choice of operative method 
is also significantly associated with the risk of developing postoperative infectious 
complications.
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 The majority of the HCAI consisted of surgical site infections, however, the combined 
impact of UTI, pneumonia and sepsis were also quite substantial. Endovascular interventions 
are generally associated with fewer infectious complications, 7.8% compared to TEA 9.3% 
and bypass 13.3%. The choice between a bypass operation and endovascular treatment for 
a claudicant translates into an 8-fold increased risk of developing an HCAI after bypass 
surgery.
The total incidence of postoperative HCAI in this study (9.7%) is somewhat lower than 
the rates of SSI after lower extremity revascularisation as reported in other studies.56, 57 We 
suspect the main reason for this discrepancy is the lack of a unified definition for SSI and a 
systematic underreporting of postoperative infections in outpatient care. Compared to studies 
that have looked at HCAI after open vascular surgery 58, the rate of infection in this study is 
considerably higher, presumably due to the chosen cohort of infrainguinal procedures and the 
inclusion of patients with gangrene.
This study has several weaknesses, which are primarily a result of the retrospective design of 
the study and the registries used for data collection. Certain parameters, such as body mass 
index (BMI)/obesity, length of operation, and length of hospital stay were not included in the 
databases. 59
Study II
 The patients were divided into four groups based on the presence or absence of infection pre – 
and postoperatively (Figure V).
Figure V. Classification of Patients in Study II
 
In the group with postoperative infection (n = 14), the infectious agent was successfully 
identified in blood and/or urine cultures in five of the 14 cases. For the other nine cases, no 
infectious agent was isolated, but there was a clinical suspicion of infection and all but one 
patient responded to antibiotics, the non-responder was diagnosed with ischaemic colitis at 
laparotomy.
In group 1, post-operative infection only, all four markers were significantly increased in 
the
24h after surgery: CD64 (P = 0.001); CRP (P = 0.001); WBC (P= 0.002); PCT (P = 0.012). 
Results for those with post-operative fever only (group 3) were similar. CD64 values were
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significantly higher, both pre- and post-operatively than for patients with no pre- or
postoperative infection (Table 1). Postoperative values of s-procalcitonin were also higher than 
those for patients with no infection (Table 1).
In group 2, pre- and postoperative infection, there was no significant difference in the CD64 
(P = 0.12, WBC (P = 0.25), and PCT (P = 0.14) values, whereas a marginal significance was
shown for CRP (P = 0.046). The postoperative CD64 values were lower than the 
corresponding
preoperative values in two cases in this group. Post-operative values of CD64 were higher
than for patients with no pre- or post-operative infection.
Based on the ROC curve analysis of the postoperative values for CD64, CRP and PCT for 
the combined group of patients with postoperative infections, CD64 as a diagnostic marker, 
had a sensitivity of 93% and a specificity of 69% (cut-off: 1.03), compared to CRP which 
had a sensitivity of 79% and a specificity of 80% (cut-off: 82) and PCT with a sensitivity of 
64% and a specificity of 78% (cut-off: 0.26).
The first aim of the study was to establish the effect of the inflammatory response due 
to surgical trauma on the degree the CD64 expression on neutrophils. Analysis of the 
pre- and postoperative values of CD64 in Group-4 (no infections), showed a significant 
difference between these values (range: 0.84 – 0.93). However, this increase, presumably 
due to surgical trauma can be considered of little clinical significance, since the range of 
values fell short of the cut-off value (1.03). It can therefore be argued, from a clinical point 
of view, that the effect of surgical trauma on CD64 expression in non-infected patients is 
negligible.
The second aim of the study was to evaluate the clinical utility of CD64 measurements in 
diagnosing bacterial infections postoperatively.
In the group with postoperative infection (n = 14) which included five proven cases of 
infection based on culture results and nine cases based on clinical signs, there was a clear 
tendency toward higher preoperative CD64 values as represented by the borderline mean 
value (0.99) for the whole group.  There was also, as expected a clear and statistically 
significant increase in the postoperative values of CD64 correlating with the postoperative 
infections. In Group –2 (n = 6), the CD64 values indicated the presence of bacterial 
infection both pre- and postoperatively (Table VI). Interestingly, there was no significant 
increase in the postoperative values, which can be due to the small size of the group or the 
insignificant effect of trauma in the presence of a clinically significant infection. To show 
the extent of the effect of trauma on CD64 postoperatively we can highlight the results 
for two patients in this group with proven preoperative bacterial infection – one with 
distal gangrene and the other with an infected prosthetic graft. The patients were operated 
with amputation and excision of infected graft, respectively. The postoperative values of 
CD64 were lower than the preoperative values. This anecdotal evidence shows not only 
the insignificant effect of trauma on the CD64 values, but also the correlation between 
removing the source of infection and the fall in the CD64 index.
Procalcitonin (PCT), which is a pro-hormone to calcitonin is another marker of 
inflammation shown to be superior to CRP in detecting bacterial infection 60. The usefulness 
of PCT measurements postoperatively, for detecting bacterial infections has not been 
unequivocally established. Studies carried out on patients undergoing thoracic surgery 
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have shown an unspecific and short-term increase following surgery 61, 62. In one of these 
studies the PCT levels returned to normal (<1ng/ml) on the third postoperative day 61, and 
increased proportionally thereafter in response to varying types of infection ranging from 
mediastinitis to septic shock. Although, PCT has been shown to be a better marker of 
infection than CRP, its use in clinical practice has been limited in most part to critically ill 
patients in intensive care units where its prognostic value is inferred from fluctuations and 
general trends in the serum concentrations over periods of one week or longer. 60, 61, 63
As it was our intention to evaluate the usefulness of CD64 measurements in the day to day 
management of patients after surgery, we chose to use the version of the Leuko64™ assay 
kit designed specifically for use on Abbott Cell-Dyn 4000® and Sapphire® instruments. 
By adopting this method of analysis, we were able to streamline the logistics for sample 
taking and analysis for all four variables (CRP, WBC, PCT and CD64), through running all 
analyses on the same instrument and thereby minimising the need for extra personnel and 
laboratory resources. The reliability of this method of analysis has been proven by both the 
producer of the kits (Trillium Diagnostics, LLC) and a published clinical study comparing 
the results from flow cytometri with those from Cell-Dyn 4000®. 64
The shortcomings in this study are due to the heterogeneity of the vascular procedures and 
patients, the relatively low number of postoperative infections, the lack of a standardised 
clinical protocol for classification of postoperative SSI and the short postoperative follow-
up period.
Table VI. Pre- and postoperative values of each marker expressed as a mean for the 
designated patient group. Neutrophil CD64 index (CD64); C-reactive protein (CRP); Total 
leukocyte count (WBC); serum-procalcitonin (PCT).
infection Marker
no Pre- or 
Postop. infection
(n = 104)
Postop. 
infection
(n = 14)
Pre- and Postop. 
infection
(n = 6)
Postop. 
fever
(n = 29)
all 
Patients
(n = 153)
CD64       Preop.
           
                Postop.
0.84
0.93
0.99
1.42
1.36
1.68
0.92
1.34
0.89
1.07
CRP        Preop.
          
                Postop.
5.9
49
12
119
83.5
130
5.4
93
10
66
WBC        Preop.
          
                Postop. 
7.2
8.8
7.1
10.4
14.3
11.3
7.3
9.9
7.5
9.2
PCT        Preop.
          
               Postop.
0.10
0.44
0.10
9.4
0.25
1.28
0.10
9.4
0.11
2.64
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Study III
The patients were categorized into four groups as shown in Figure VI.
Figure VI. Classification of patients in Study III
The cytokines analysed in the study are presented in Table VII.
Preoperative versus Postoperative cytokine analyses 
Eighty-eight per cent (22/25) of investigated cytokines had lower postoperative mean values 
compared to preoperative values. IL-6 was the only cytokine that showed a significant 
increase postoperatively (P < .05). CRP (P < .028) and CD64 (P < .001) also showed 
significant increases postoperatively.
Patients with postoperative infection  
Associations with postoperative infection were shown for pre- and postoperative values of 
IL-2 and IL-13, as well as, postoperative values of MIP-1α, IP-10 and RANTES (P < .05).
Patients with early postoperative fever (EPOF)  
Associations with EPOF were shown for pre- and postoperative values of IL-10 and IFN-α 
in addition to preoperative values of GM-CSF, MIP-1α and postoperative values of IL-6 and 
Eotaxin.
Cytokine, CRP and CD64 analyses based on postoperative infection or fever  
Analysis of the postoperative values of CRP (P < .001) and CD64 (P = .028) together 
with IL-6 (P = .006) and IL-10 (P = .02) using logistical regression showed a significant 
association with postoperative infection or fever when analysed individually. Combined 
analysis with CRP and CD64 together with either IL-6 or IL-10 values showed a statistical 
significance when employing a one-tailed test.
The logistical regression analysis showed a significant predictive value for combining either 
IL-6 or IL-10 with CRP and CD64, in the diagnosis of postoperative infection. This implies a 
significant supplementary role for IL-6 and IL-10 in the postoperative diagnosis of infection.
Early postoperative fever (EPOF) described as fever (temp. > 38°C) during the first 48 
hours after surgery is quite common in vascular surgery. 71 The aetiology of the fever can 
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be either infectious as caused by endotoxins or an acute phase response to surgical trauma, 
both of which are mediated by cytokines. 71, 72 Further complicating the picture, is the finding 
that postoperative infections do not necessarily present with fever 73, as shown in our series 
where only two of the postoperative infections (1case of pneumonia and 1case of UTI) 
were accompanied by fever. Therefore, the patients with fever but no other clinical signs of 
infection have been assigned to a separate group.
There was a significant change in values for eight of the 22 cytokines that showed a 
postoperative decrease. All eight are implicated in the pro-inflammatory response, where 
four (IL-1β, IL-2, IL-12p40 and GM-CSF) induce a pro- inflammatory response through the 
activation of T cells and mononuclear phagocytes (MNP), and the remaining four (IP 10, 
MIG, Eotaxin and MCP-1) function as chemoattractants for various immunocompetent cell 
types. A possible explanation for this, may involve the role of anaesthetic agents and surgical 
stress in attenuating the cytokine induced pro-inflammatory response. Previous studies 
have shown impaired neutrophil chemotaxis, MNP phagocytic capacity and a decline in the 
number of circulating NK-cells postoperatively. 74
Due to the paucity of postoperative infections in this material and the relatively small number 
of surgical procedures in each category, the results do not lend themselves to subgroup 
analyses based on type of infection or surgical procedure and neither can we draw any 
conclusions about the predictive value of these cytokines. Furthermore, we cannot specify the 
source of the cytokines, as the samples were not differentiated into various cell type origin.
In addition to the pro-inflammatory cytokines and chemokines that have shown significant 
variations in this study, there was also a group of anti-inflammatory cytokines represented 
by IL-10 and IL-13. The role of IL-10 in bacterial disease has not been fully elucidated, 
but it is thought that through its inhibition of pro-inflammatory cytokines, it provides a 
protective function against the detrimental effects of systemic inflammation. IL-13 manifests 
its anti-inflammatory effects through the inhibition of IL-1β, IL-6, IL-8 and TNF-α 65. To our 
knowledge, this is the first report linking IL-10 plasma levels to perioperative infection.
Results and Discussion
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Cytokines function ref.
Pro-inflammatory
il-1β Stimulates T-cell proliferation; enhances PGE2 synthesis – induces fever
65
il-2 Growth factor/activator for T cells, NK cells and B cells 65
il-2r Receptor for IL-2; enhances lymphocyte proliferation 65
IL-4 B cell proliferation; IgE production; inhibition of IL-1, IL-6 and IL-8 65
il-5 Eosinophil differentiation; enhances T cell toxicity 65
il-6 Stimulation of acute phase protein synthesis in liver; growth factor for B cells
66
il-7 Growth factor for B cells and T cells 65
il-12p40 Differentiation of TH1 cells. Chemoattractant for macrophages 67
il-15 Proliferation of T lymphocyte and NK cells 65
il-17 Stimulates T cell proliferation 65
gM-Csf Stimulates neutrophils, eosinophils and mononuclear phagocytes 65
tnf-α Stimulates PGE2 synthesis; induces production of acute phase reactant 
proteins by the liver
65
Anti-inflammatory
il-1ra IL-1 receptor antagonist 65
il-10 Inhibition of IFN-γ production by T cells and NK cells 65
il-13 Inhibits the production of IL-1β, TNF-α, IL-8 and IL-6 65
Interferons
ifn-α Anti-viral  and anti-proliferative activity 68
ifn-γ Activation of macrophages; regulation of PMN CD64 expression 69
Chemokines
il-8 Mediates recruitment and activation of neutrophils 65
MiP-1α Induce monocyte and T lymphocyte migration 65
MiP-1β Induce monocyte and T lymphocyte migration 65
iP 10 Chemoattractant for MNP, T cells, NK cells and dendritic cells 65
Mig T cell chemoattractant 65
eotaxin Eosinophil chemoattractant 70
rantes Chemoattractant for monocytes, eosinophils, basophils and mast cell 70
MCP-1 Chemoattractant for neutrophils, monocytes and lymphocytes 65
Table VII. Summary of the cytokines and their major functions and effects.
(IL: interleukin; PGE
2: 
prostaglandin E
2
; GM-CSF: granulocyte macrophage-colony 
stimulating factor; TNF-α: tissue necrosis factor-α; IFN-γ: interferon-γ; IFN-α: interferon- α; 
MIP-1α/β: macrophage inflammatory protein-1α/β; IP 10: interferon-γ induced protein;
MIG: monokine induced by interferon gamma; RANTES: regulated upon activation normal 
T-cell expressed and secreted; MCP-1: monocyte chemoattractant protein-1)
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Study IV
The indications for intervention were divided into claudication 27% (n= 2 659), CLI 
17% (n=1 681) and gangrene 56% (5 552). The treatment modalities were comprised of 
endovascular intervention 59% (n=5 865), TEA 13.5% (n=1 332) and bypass surgery 27% 
(n=2 697). 
Figure VII. Total antibiotic prescriptions
There was a 92% increase in incidence rate for the 1-month postoperative period compared 
to the preoperative period (P < .001) followed by a 9% decrease in the incidence rate for the 
extended (1-6 months) postoperative period (P < .001).
Patients undergoing endovascular interventions had a 52% increase in the rate of dispensed 
antibiotic prescriptions postoperatively, compared to the preoperative period and a 15% 
decrease during the extended postoperative period.
The overall incidence of 30-day postoperative antibiotic prescription per patient was 33%. 
These were comprised of antibiotics for skin-and-soft-tissue infections 67%, UTI 21%, and 
respiratory tract infections (RTI) 12%. During the month leading to the index operation, 32% 
of patients with postoperative antibiotics had received an antibiotic prescription.
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Figure VIII. Antibiotic prescriptions for the endovascular group.
In the endovascular group, there was an increase in the incidence of UTI-antibiotics 
prescriptions during the 30-day postoperative period compared to the preoperative period 
(P < .001). In the subgroup analysis, UTI-antibiotics dominated the postoperative 30-day 
period for claudicants (P < .001), as opposed to skin-and-soft-tissue antibiotics, which were 
prominent in the ulceration/gangrene group (P < .001), during the same period. Patients with 
CLI without ulceration showed an increase in both skin-and-soft-tissue (P = .016), and UTI-
antibiotics (P < .001) postoperatively, compared to the preoperative period.
Analysis of the bypass group showed a 30-day postoperative increase in the skin-and-soft-
tissue and UTI-antibiotics prescriptions relative to the preoperative period for all three 
categories of lower limb ischaemia (P < .001).
By cross-matching the national vascular and the prescribed drug registers we have sought 
to use antibiotic prescription and dispensation as a surrogate marker for identifying 
postoperative infections. One-third of the patients in our cohort received an antibiotic 
prescription during the first month after surgery. Patients undergoing endovascular 
revascularization have a substantial increase in the burden of infection postoperatively, 
partly explained by UTI-antibiotics. This is best demonstrated by the results for claudication 
patients, which showed a 62% increase in the cumulative incidence rate of total antibiotic 
prescriptions during the 30-day postoperative period compared to the preoperative period. 
This highlights the importance of post-discharge surveillance for endovascular patients.
Disregarding the third of the patients with preoperative antibiotics, there still remains a group 
of patients, comprising more than a fifth of the whole cohort, who received antibiotics after 
discharge. 
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The extrapolation from dispensed antibiotic prescription to an actual HCAI-event and by 
extension the categorization of a particular infectious complication is admittedly, contentious. 
As we have already mentioned, the use of antibiotic prescriptions, can at best be considered 
a surrogate for clinical diagnosis. The defining criterion for diagnosis of an infectious 
complication is the treating physician’s clinical judgment, which can, in certain circumstances 
lead to a risk of antibiotic over-prescription.
In addition to the limitations posed by the retrospective analysis of registry data, a further 
point of concern is the classification of the different types of postoperative HCAI based 
on the type of antibiotics. This is based on the assumption that most physicians follow the 
common practice of treating uncomplicated cases of RTI, UTI and SSI with specific groups 
of antibiotics best suited for the particular infection. The resulting classification is far from 
exact due to an inevitable overlapping of indications for certain types of antibiotics.
Results and Discussion
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generAl disCussion And 
future PersPeCtives
The somatic, psychological, and socioeconomic burden of healthcare associated infections 
in vascular surgery can be debilitating, for both the healthcare system and the individual. 
Patients with postoperative SSI often require prolonged periods of in-hospital care or 
readmission resulting in loss of productivity and income, increased costs and varying degrees 
of psychological impairment. More serious cases of infection involving prosthetic aortic 
grafts can lead to major reoperations and/or life-long treatment with antibiotics or antifungal 
medications.
The topics discussed in this thesis touch upon two of the main challenges in tackling this 
subject. The issue of surveillance and follow-up of patients, as discussed in studies I and IV 
are of importance to the healthcare system and form the backbone of a process in which data 
collected and analyzed are disseminated to the institutions, leading to decisions concerning 
corrective and preventive measures, which can then be evaluated by the surveillance systems. 
Surveillance strategies can vary depending on the setting and the available resources. 75, 
76 There are, however, certain requirements that need to be met in order for a surveillance 
method to be of value. These requirements, listed in a 2002 WHO report on the “Prevention 
of Hospital-acquired infections – a practical guide” are as follows: 
- simplicity – aiming to minimize costs and efforts to promote participation 
- flexibility – to allow adaptive changes when needed
- acceptability – judged by the quality of data
- consistency – by using standardized definitions and protocols
- sensitivity – requiring consistency and representativeness of the collected data
- specificity – requiring standardized and precise definitions and trained personnel
Active surveillance methods can be broadly divided into prevalence and incidence studies. 
Prevalence studies are usually carried out in single healthcare institutions and provide a 
snapshot of the current status. They are relatively cheap, fast and less labour intensive than 
longitudinal studies. Incidence or continuous studies are generally more cumbersome but 
provide a range of information such as rates of infection and associated risk factors that are 
necessary in detecting patterns and implementing preventive measures. 
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The results from Study I, which showed a 30-day incidence rate of 9.7% for postoperative 
infections, were suspected of underestimating the actual rate. In study IV, using the same 
cohort and national registries (NPR/Swedvasc), we used antibiotic prescription as a surrogate 
for post-discharge surveillance for HCAI. Our findings from Study IV showed a 30-day 
incidence rate of HCAI more than double the previous results. The observed difference 
in the rates of 30-day HCAI may to some extent be explained by differences in coding 
and classification in the registries, but cannot fully account for the substantial discrepancy 
between the rate of antibiotic prescriptions and the recorded diagnoses of infection.
The retrospective register based methods used in this work have the advantage of reducing 
the cost and workload in identifying the rates and patterns of infection and associated risk 
factors. Using antibiotic prescription and dispensation for post-discharge follow-up can be an 
extremely cost-effective method for both identifying the scope of the problem and evaluating 
the effects of procedural improvements. As mentioned earlier, the applicability of the results 
and conclusions from these studies are directly related to the quality of data in the registries. 
As such, the Swedish national registries provide an invaluable source of data for quality 
control and follow-up of vascular patients.
The other main challenge, considered in this work, is the accurate diagnosis, preferably as 
early as possible, of postoperative bacterial infections. Early diagnosis and treatment of 
these infections in vascular patients are of paramount importance, if serious consequences 
are to be avoided. The presence of acute inflammation caused by surgical trauma is a major 
confounding factor when using the traditional laboratory markers such as total leucocyte 
counts and CRP.  The pursuit of more sensitive and specific markers is on-going and will 
continue. In studies II and III, we have looked at some possible candidates that upon initial 
evaluation seem promising. Neutrophil CD64 expression, procalcitonin, and the cytokines 
IL-6 and IL-10 have all shown potential as useful laboratory markers, however it is unlikely 
that any one of these will become a gold standard on its own. It is more likely that a battery of 
tests will be needed to distinguish between the acute inflammatory response to infection and 
surgical trauma.
The topic of preventive measures has not been discussed in this thesis as it represents 
another vast field of research ranging from experimental techniques such as carbon dioxide 
insufflation of the surgical wound during surgery 77, the use of antimicrobial sutures 78, 
negative pressure wound closure devices 79, 80 and the eventual benefits of supplemental 
oxygen inhalation 81 to the tentative benefits of preoperative procedures such as showering, 
hair removal and various antiseptic skin preparations. 82, 83
A relevant area for future research is the presumed link between the inflammatory response 
to infection and the increased risk of thrombosis as alluded to by the results in the first 
study which showed a higher rate of amputation among patients with postoperative 
infection compared to those without infection and previous research highlighting a possible 
connection. 84
The way forward should ideally involve a three-pronged approach consisting of further 
clinical evaluation of new laboratory markers, further refinement of perioperative techniques 
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and procedures for reducing postoperative infections and improved prospective surveillance 
of patients both in hospital and post-discharge with the help of standardized, validated 
protocols and personnel with the relevant competence.
General Discussion and Future Perspectives
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ConClusions
The conclusions from this thesis are the identification of healthcare associated infections 
(HCAI) as a major group of complications in lower extremity revascularization, particularly, 
in endovascular procedures, which have not been formerly associated with a substantial 
degree of infections and the potential viability of neutrophil CD64 in combination with PCT, 
CRP, IL-6 and IL-10 as a battery of laboratory tests for early detection of postoperative 
HCAI. 
More specifically:
• We have determined the rate of infection within 30 days, both in-hospital and after 
discharge, for patients undergoing infrainguinal, open or endovascular revascularizations 
in a large population based cohort. We have also identified the significant risk factors for 
the development of postoperative infection, 30-day mortality and one-year amputation 
for this cohort. Furthermore, we have has shown the effect of the interaction between 
different classes of lower extremity ischaemia and choice of operative method on 
postoperative HCAI. 
• We have demonstrated the minimal effect of surgically induced inflammation on the up-
regulation of neutrophil CD64 receptors. CD64 as a marker for postoperative infection 
in vascular surgery has shown to have a higher sensitivity than CRP and PCT and may 
represent an improved diagnostic method.
• We have shown a positive correlation between perioperative infection and both pro- and 
anti-inflammatory cytokines, represented by IL-6, and IL-10 and IL-13, respectively. 
To our knowledge this is the first report linking IL-10 plasma levels to perioperative 
infection. 
• Antibiotic treatment can be a useful marker for postoperative infections in vascular 
surgery. Our results emphasize the appreciable burden of disease and illustrate the 
pattern of antibiotic treatment of postoperative HCAI in patients undergoing treatment 
for severe lower extremity arterial disease. Based on these results, we suspect a previous 
underestimation of the total incidence of postoperative HCAI in patients treated with 
infrainguinal revascularization. This underscores the need for comprehensive follow-up 
regimens for this vulnerable category of vascular patients.
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